Meglumine antimoniate

Meglumine antimonate

  • P01CB01
  • QP51AB01

Template: Infobox chemical / molecular formula search available

N- Methylglucaminantimonat is a drug which is used in the treatment of leishmaniasis. It is manufactured by Aventis in the order of 5 million per year ampoules.

It was recorded in 1988 in the list of essential drugs of the World Health Organization.

Trade names

  • Glucantime
CAS registry number PubChem Anatomical Therapeutic Chemical Classification System Active ingredient WHO Model List of Essential Medicines
561742
de